Literature DB >> 33057818

Trends in integrative medicine and health consults: differences between cancer survivors and patients without cancer.

Noël M Arring1,2, Denise Millstine3, Debra L Barton4, Karen S Lyons5, Marlene Girardo6, Amy Hutson7, Lillian M Nail8.   

Abstract

OBJECTIVES: The objectives were to compare patients with and without cancer who sought an integrative health (IH) consult and reasons for seeking a consult.
DESIGN: Descriptive cross-sectional study that employed a secondary analysis of an integrative health database supplemented by a retrospective medical record review. SETTING/LOCATION: Integrative Medicine and Health program in a Southwestern United States academic medical center.
SUBJECTS: Eight hundred thirty-nine adults over the age of 18 seeking IH consultation.
RESULTS: The number of complementary therapies reported prior to consult were not significantly different between groups. The most reported complementary therapies used by cancer survivors were multivitamins, exercise, and turmeric. Patients without cancer reported significantly higher pain levels than cancer survivors. Cancer survivors reported significantly higher energy, sleep levels, overall health, spiritual wellbeing, and significantly better relationships compared to patients without cancer. Cancer survivors reported fatigue and cancer as the top reasons for IH consult.
CONCLUSION: Participants without cancer reported higher levels of pain and lower levels of energy, sleep, overall health, spiritual wellbeing, and relationships compared to cancer survivors. However, cancer survivors still reported levels of unmanaged symptoms. Complementary therapy use prior to IMH consult was similar between groups; however, IMH providers recommended more treatments for patients without cancer. Our results highlight that more evidence is needed to guide IMH recommendations, especially for cancer survivors who may still be in treatment. Additionally, our results support evidence-based recommendations that all cancer survivors should be assessed for complementary therapy use and provided counseling by qualified providers on their advantages and limitations.

Entities:  

Keywords:  Cancer; Complementary and alternative medicine; Integrative health; Physician referrals; Symptoms

Year:  2020        PMID: 33057818     DOI: 10.1007/s00520-020-05815-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  20 in total

Review 1.  How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.

Authors:  Markus Horneber; Gerd Bueschel; Gabriele Dennert; Danuta Less; Erik Ritter; Marcel Zwahlen
Journal:  Integr Cancer Ther       Date:  2011-10-21       Impact factor: 3.279

2.  Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

Authors:  Gary E Deng; Moshe Frenkel; Lorenzo Cohen; Barrie R Cassileth; Donald I Abrams; Jillian L Capodice; Kerry S Courneya; Trish Dryden; Suzanne Hanser; Nagi Kumar; Dan Labriola; Diane W Wardell; Stephen Sagar
Journal:  J Soc Integr Oncol       Date:  2009

3.  Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey.

Authors:  Joel G Anderson; Ann Gill Taylor
Journal:  J Altern Complement Med       Date:  2012-03       Impact factor: 2.579

4.  Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Gary E Deng; Sarah M Rausch; Lee W Jones; Amitabh Gulati; Nagi B Kumar; Heather Greenlee; M Catherine Pietanza; Barrie R Cassileth
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

5.  Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients.

Authors:  Carmen Loquai; Dagmar Dechent; Marlene Garzarolli; Martin Kaatz; Katharina C Kaehler; Peter Kurschat; Frank Meiss; Oliver Micke; Ralph Muecke; Karsten Muenstedt; Annette Stein; Dorothée Nashan; Christoph Stoll; Irene Schmidtmann; Jutta Huebner
Journal:  Eur J Cancer       Date:  2016-12-14       Impact factor: 9.162

6.  The use of complementary and alternative medicine by patients in routine care and the risk of interactions.

Authors:  Rachel Firkins; Hannah Eisfeld; Christina Keinki; Jens Buentzel; Andreas Hochhaus; Thorsten Schmidt; Jutta Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-22       Impact factor: 4.553

7.  Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes.

Authors:  Moshe Frenkel; Lorenzo Cohen; Noemi Peterson; J Lynn Palmer; Kay Swint; Eduardo Bruera
Journal:  Integr Cancer Ther       Date:  2010-08-11       Impact factor: 3.279

Review 8.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

9.  The use of Complementary and Alternative Medicine by cancer patients.

Authors:  Mariama Adams; Andrew Paul Jewell
Journal:  Int Semin Surg Oncol       Date:  2007-04-30

10.  Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer.

Authors:  Garrett Strizich; Marilie D Gammon; Judith S Jacobson; Melanie Wall; Page Abrahamson; Patrick T Bradshaw; Mary Beth Terry; Susan Teitelbaum; Alfred I Neugut; Heather Greenlee
Journal:  BMC Complement Altern Med       Date:  2015-11-19       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.